We are live on ! Find out more
HAIM

Hunter Associates Investment Management Portfolio holdings

AUM $868M
1-Year Est. Return 32.25%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.12%
AUM
$238M
AUM Growth
+$3.39M
Cap. Flow
-$3.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
30.82%
Holding
164
New
8
Increased
30
Reduced
66
Closed
3

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.45M
2
PG icon
Procter & Gamble
PG
+$1.01M
3
AMGN icon
Amgen
AMGN
+$509K
4
IBM icon
IBM
IBM
+$451K
5
TROW icon
T. Rowe Price
TROW
+$435K

Sector Composition

Rank Sector Weight
1 Healthcare 24.26%
2 Technology 21.27%
3 Industrials 14.77%
4 Consumer Staples 9.04%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
151
UnitedHealth
UNH
$366B
$205K 0.09%
1,250
-250
-17% -$40.9K
DUK icon
152
Duke Energy
DUK
$94.8B
$201K 0.08%
+2,453
New +$195K
PLUG icon
153
Plug Power
PLUG
$3.03B
$14K 0.01%
+10,000
New +$11.5K
DFS
154
DELISTED
Discover Financial Services
DFS
-3,300
Closed -$238K
NXGN
155
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-20,000
Closed -$263K
CYS
156
DELISTED
CYS Investments Inc.
CYS
-14,000
Closed -$108K

Similar funds

Hunter Associates Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Hunter Associates Investment Management held 164 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Hunter Associates Investment Management's Q1 2017 filing shows 8 new, 30 increased, 66 reduced and 3 closed positions. Its largest new stake was Endo International plc: 33,900 shares worth $378K. The largest sale was Pfizer, an estimated $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Hunter Associates Investment Management's largest Q1 2017 buy was Endo International plc: 33,900 shares worth $378K.
  • Hunter Associates Investment Management added most to Weyerhaeuser in Q1 2017, an estimated $1.83M increase.
  • Hunter Associates Investment Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $1.45M.
  • Hunter Associates Investment Management fully exited NextGen Healthcare, Inc. Common Stock in Q1 2017, selling an estimated $263K.
  • Hunter Associates Investment Management's ten largest holdings make up 31% of its $238M portfolio in Q1 2017.
  • Hunter Associates Investment Management opened 8 new positions and closed 3 in Q1 2017.
  • Hunter Associates Investment Management's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Hunter Associates Investment Management's 13F filing for Q1 2017, filed 10 May 2017.